10月15日，Core Scientific盘中下跌8.07%，报12.65美元/股，成交额5881.27万美元。
消息面上，公司日前披露拟议出售证券公告，市场同时关注管理层持股变动相关文件，对股价形成短线压力。
从背景看，此前公司曾获机构买入或上调目标价，并推进与AMD的数据中心合作、完成Polaris DS收购及6亿美元信贷安排；但就时点而言，最新拟售证券相关披露更接近本次异动，成为更直接的公开信息扰动。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.